Applications

Viral vectors

Accelerate and de-risk your viral vector upstream development with Culture

Culture accelerates and de-risks upstream process development for viral vectors by parallelizing experiments to reduce program bottlenecks.

Bioreactor with media - Culture Bioscience

Benefits

Increase speed to clinic and manufacturing milestones

Save 6-18 months in your protein therapeutic development timeline with access to our cloud-connected bioreactor facility. Instead of dedicating time and resources to building your own lab infrastructure, focus on advancing your protein therapeutic pipeline. Our streamlined workflows and advanced systems are purpose-built to accelerate key milestones in clinic and manufacturing, helping you bring innovative therapies to market faster.

Scale-out without the delays of lab build, investment, and staffing

Avoid the costly and time-consuming challenges of constructing a dedicated process development facility. With Culture, you can run process development or characterization Design of Experiments (DOEs) on-demand, without the delays associated with hiring specialized staff or securing significant capital investments. Our platform enables you to scale-out with efficiency, supporting your team in generating valuable insights and data at a fraction of the time.

Run massive DOEs to optimize viral genome titer, capsid titer, or other process residuals

Our team and innovative cloud-connected bioreactors support large DOEs for process optimization. Evaluate process optimizations including plasmid ratios, viable cell density at transfection, agitation, pH, and other bioreactor specific parameters.

Capabilities

Unleash your construct screening

Use our bioreactors to evaluate your viral vector constructs to get to your most desired outcome. Scaling-out your construct screening will save time and get you to your best outcome faster.

Parallelize upstream and downstream development with material generation

Generate material for downstream, drug product, and analytical activities. Outsource routine material supply to supplement your upstream capacity.

In-house viral vector analytics for faster process development

Analyze your vector product attributes with ddPCR, capsid ELISA, HCP, and HCDNA. Monitor your process with VCD, pH, and metabolites.

Blog

Latest resources

Announcement

Culture Biosciences unveils Stratyx™ 250, the first cloud-integrated, mobile bioreactor for cell culture process development

April 1, 2025
Documentation

Stratyx™ 250 Hardware & Single Use Technical Specifications

April 1, 2025

Optimize your bioprocess with Culture